| Amy Catherine Joanou, NP | |
|
426 8th St Ste 305, Glen Dale, WV 26038-1451 | |
| (304) 843-5041 | |
| Not Available |
| Full Name | Amy Catherine Joanou |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 426 8th St Ste 305, Glen Dale, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255978292 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 55915 (West Virginia) | Primary |
| Entity Name | Lung Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740491315 PECOS PAC ID: 1254301195 Enrollment ID: O20040728001426 |
News Archive
Lightning fast connections between robotic limbs and the human brain may be within reach for injured soldiers and other amputees with the establishment of a multimillion-dollar research center led by SMU engineers.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration has issued 510(k) clearance to the Simplexa Influenza A H1N1 (2009) test on the 3M Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is the first to be cleared by the FDA for use as an aid in the detection and differentiation of influenza A and 2009 H1N1 influenza viral RNA.
Setting the stage for possible advances in pain treatment, researchers at The Johns Hopkins University and the University of Maryland report they have pinpointed two molecules involved in perpetuating chronic pain in mice. The molecules, they say, also appear to have a role in the phenomenon that causes uninjured areas of the body to be more sensitive to pain when an area nearby has been hurt.
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces the successful completion of preclinical toxicology testing on the gold nanoparticle carrier system that forms the fundamental basis for Emergex's entire infectious disease vaccine platform.
Researchers studying zebrafish have found that genes linked to autism spectrum disorder and other developmental brain abnormalities may be playing a role in people who cannot control their eye movements.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy Catherine Joanou, NP Po Box 6244, Wheeling, WV 26003-0722 Ph: (304) 843-5041 | Amy Catherine Joanou, NP 426 8th St Ste 305, Glen Dale, WV 26038-1451 Ph: (304) 843-5041 |
News Archive
Lightning fast connections between robotic limbs and the human brain may be within reach for injured soldiers and other amputees with the establishment of a multimillion-dollar research center led by SMU engineers.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration has issued 510(k) clearance to the Simplexa Influenza A H1N1 (2009) test on the 3M Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is the first to be cleared by the FDA for use as an aid in the detection and differentiation of influenza A and 2009 H1N1 influenza viral RNA.
Setting the stage for possible advances in pain treatment, researchers at The Johns Hopkins University and the University of Maryland report they have pinpointed two molecules involved in perpetuating chronic pain in mice. The molecules, they say, also appear to have a role in the phenomenon that causes uninjured areas of the body to be more sensitive to pain when an area nearby has been hurt.
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces the successful completion of preclinical toxicology testing on the gold nanoparticle carrier system that forms the fundamental basis for Emergex's entire infectious disease vaccine platform.
Researchers studying zebrafish have found that genes linked to autism spectrum disorder and other developmental brain abnormalities may be playing a role in people who cannot control their eye movements.
› Verified 7 days ago
Cristyn Rene Davis, MSN, APRN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 426 8th St Ste 305, Glen Dale, WV 26038 Phone: 304-559-3491 | |
Aliya Zainab Okey, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 426 8th St Ste 102, Glen Dale, WV 26038 Phone: 304-845-8444 | |
Mrs. Melissa Ann Kenamond, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 426 8th St, Ste. 305, Glen Dale, WV 26038 Phone: 304-483-5041 Fax: 304-845-4586 | |
Sarah Sampson, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 426 8th St Ste 305, Glen Dale, WV 26038 Phone: 304-843-5041 | |
Brenda Dennis, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 426 8th St Ste 102, Glen Dale, WV 26038 Phone: 304-845-8444 Fax: 304-845-8446 | |
Amber Tolon, NP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 800 Wheeling Ave, Glen Dale, WV 26038 Phone: 304-843-3211 |